Trial intelligence / Profile preview

Systemic bioavailability of gentamicin from Herafill Beads G vs Garamycin Schwamm after hip-cup arthroplasty

DRKS00023902Phase 2Completed

Sponsor
Heraeus Medical
Start
Jan 2021
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

A Phase 2 trial of gentamicin in aseptic loosening of hip arthroplasty (ALHA), sponsored by Heraeus Medical. Started Jan 2021; status: completed.

02

Drugs

gentamicin
03

Conditions

aseptic loosening of hip arthroplasty (ALHA)

Beyond the preview

Go deeper on DRKS00023902.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on DRKS00023902.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call